U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -0.21% | 0.82% | 50.67% | -80.31% | 4.67% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.38% | 1.98% | -53.92% | 134.91% | -17.96% |
| Change in Net Operating Assets | -15.06% | 719.48% | -95.21% | 476.34% | 266.07% |
| Cash from Operations | 33.38% | 51.46% | -108.93% | 70.56% | -5.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -45.83% | -70.17% | 226.22% | 117.65% | -71.67% |
| Total Debt Repaid | 0.00% | 0.00% | 93.51% | -42.59% | -39.66% |
| Issuance of Common Stock | -100.00% | 400.00% | -60.00% | -88.89% | 350.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -78.70% | -34.60% | 232.13% | -82.77% | 129.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.26% | 582.93% | 83.53% | -373.63% | 108.46% |
